InFLAMES Flagship
- TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis (2023)
- TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)
- TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis (2026)
- Tukea ukrainalaisille tieteentekijöille (2022)
- Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC (2026)





